Our Products
Cardiovascular Drug-Eluting Coronary Stent System - Firebird - Firebird2 Coronary Stent System - Mustang - Tango PTCA Balloon Dilatation Catheter - Jive - Catenaccio - Scipio/Pioneer Neurovascular Intracranial Stent System - Apollo Distal Protective Device - Aether Endovascular AAA/TAA Stent Graft System
- Aegis T
- Hercules T - Hercules B - Aegis B Peripheral Vascular Distal Protective Device - Aether Surgical Stent Graft System - Cronus Diabetes Management Insulin Pump - La Fenice Insulin Pump Electrophysiological EP Ablation Catheters - FireMagic EP Mapping Catheter - EasyFinder Orthopedics Anterior Cervical Plate System -Antelope™ Spinal Posterior Fixation System -Firefox™ Cervical Fusion Device -Firestone™ Lumbar & Thoracic Fusion Device -Futago™
Home
Our Products
Cardiovascular
Drug-Eluting Coronary Stent System
Firebird2
Rapamycin-Eluting Coronary CoCr Stent System
The FIREBIRD2™ Rapamycin-Eluting CoCr Coronary Stent is the second generation DES of MicroPort, which based on the new cobalt chromium alloy stent platform. It uses polyolefin polymer, which makes the coating property very remarkable.
L605 Cobalt-Chromium super alloy laser-cut stent
Strut thickness: 0.0034"
Excellent Flexibility and Conformability
Strong radial strength
Crossing profile: 0.039"
Metal Coverage Area 11.6%-13.7%
MRI compatible
Stent design: Sinuous waves balance flexibility and radial strength; Open cell Design offers easy access to side branches
Semi-compliance balloon
FIREBIRD2™ vs FIREBIRD™
34% increase in flexibility
15% increase in supporting strength
Better fatigue and corrosion resistant performance than stainless steel
Stronger and better radiopacity with lower strut thickness
Drug release rate at 30-Day: over 80%
Late lumen loss is low to 0.05mm (in-stent), binary restenosis rate is 1.3% (in-segment), and volume obstruction is extremely low to 1.26% at 6 months.
In-Vitro Release Profile of Sirlimus from Polymer-Coated Stents